During the past decade, St. Vincent Healthcare Cancer Care Services conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 172 clinical trials were completed, i.e. on average, 141% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 58 clinical trials were completed. i.e. 116% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Vincent Healthcare Cancer Care Services" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "Alliance for Clinical Trials in Oncology" with 73 trials sponsored, "SWOG Cancer Research Network" with 64 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored and "NSABP Foundation Inc" with 14 trials sponsored. Other sponsors include 76 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincent Healthcare Cancer Care Services" #1 collaborator was "National Cancer Institute (NCI)" with 175 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator and "SWOG Cancer Research Network" with 10 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "St. Vincent Healthcare Cancer Care Services" are "Breast Cancer" (40 trials), "Lung Cancer" (20 trials), "Lymphoma" (20 trials), "Leukemia" (14 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials). Many other conditions were trialed in "St. Vincent Healthcare Cancer Care Services" in a lesser frequency.

Most popular intervention types in "St. Vincent Healthcare Cancer Care Services" are "Drug" (269 trials), "Other" (146 trials), "Biological" (120 trials), "Procedure" (47 trials) and "Radiation" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (60 trials), "Quality-of-Life Assessment" (36 trials), "placebo" (32 trials), "Paclitaxel" (28 trials) and "Bevacizumab" (25 trials). Other intervention names were less common.

The vast majority of trials in "St. Vincent Healthcare Cancer Care Services" are 268 trials for "All" genders, 47 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "St. Vincent Healthcare Cancer Care Services". undefined are not yet recruiting, 39 are recruiting, 104 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 150 completed trials in St. Vincent Healthcare Cancer Care Services, 4 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in St. Vincent Healthcare Cancer Care Services, 17 "Phase 1" clinical trials were conducted, 143 "Phase 2" clinical trials and 158 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".